LIGAND PHARMACEUTICALS INC
LGND
30 insider filings · Latest: Jun 16, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 20, 2024 | Sep 20 9:39 PM | Espinoza Octavio | Proposed Sale | 1,275 | $103.94 | $132.5K | — | View → |
| Aug 28, 2024 | Aug 28 8:39 PM | Reardon Andrew | Proposed Sale | 1,500 | $106.39 | $159.6K | — | View → |
| Aug 22, 2024 | Aug 22 10:05 PM | Korenberg Matthew E | Proposed Sale | 18,858 | $105.03 | $2.0M | — | View → |
| Nov 11, 2024 | — | Korenberg Matthew E | Proposed Sale | 32,183 | $120.33 | $3.9M | — | View → |
← Previous
Page 4 of 4
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Mar 6 11:51 PM | Andrew ReardonCLO & Secretary | Option Exercise | 5,000 | $52.27 | 54,444(D) | View → |
| Mar 4, 2026 | Mar 6 11:49 PM | Octavio EspinozaChief Financial Officer | Option Exercise | 2,073 | $80.72 | 0(D) | View → |
| Mar 3, 2026 | Mar 5 4:05 PM | Stephen L SabbaDirector | Option Exercise | 2,034 | $69.51 | 0(D) | View → |
← Previous
Page 2 of 2